Correlations between P53 expression and clinicopathologic factors and the prognosis of Luminal breast cancer
Song Fangbin, Li Shanbao, Zhang Jianbing, Wu Junyi, Jin Tao, Qin Jun, Wang Ye, Wang Min, Xu Junming
2016, 43 (10):
728-732.
doi: 10.3760/cma.j.issn.1673-422X.2016.10.002
ObjectiveTo investigate the correlations between P53 expression and clinicopathologic factors and prognosis of Luminal breast cancer. MethodsFrom January 2009 to December 2012, a total of 283 patients with Luminal breast cancer in the Shanghai General Hospital Affiliated to Shanghai Jiaotong University were included. P53 expressions of them were assayed by immunohistochemistry. Survival analysis was applied using KaplanMeier curve and Logrank test. Single factor analysis and mutiplefactor analysis were applied using Cox proportional hazard regression model. ResultsThe rate of P53 expression was associated with tumor size (χ2=6.285, P=0.043), lymph node metastasis (χ2=15.881, P=0.000), histological grade (χ2=8.132, P=0.043) and Ki67 (χ2=6.476, P=0.039), but it was not associated with age (χ2=0.955, P=0.328), menopausal status (χ2=3.808, P=0.051), pathological pattern (χ2=0.847, P=0.655), estrogen receptor (χ2=1.867, P=0.172), progesterone receptor (χ2=0.937, P=0.333) and human epidermal growth factor receptor2 (χ2=0.110, P=0.741). In all the 283 patients, the 5year relapsefree survival rates for P53positive group and P53negative group were 66.7% and 90.7% respectively (χ2=12.609, P=0.000), while the 5year overall survival rates were 84.4% and 93.4% respectively (χ2=4.153, P=0.042), with significant differences. In Cox mutiplefactor analysis, lymph node metastasis (HR=2.484, 95%CI: 1.3934.431, χ2=9.497, P=0.002) and P53 overexpression (HR=3.627, 95%CI: 1.06112.401, χ2=4.220, P=0.040) were independent prognostic factors for the relapsefree survival of patients with Luminal breast cancer, and lymph node metastasis (HR=3.451, 95%CI: 1.8916.297, χ2=16.290, P=0.000) and higher histological grade (HR=2.806, 95%CI: 1.0917.219, χ2=4.582, P=0.032) were independent prognostic factors for overall survival. ConclusionP53 overexpression of patients with Luminal breast cancer is associated with prognostic factors such as lymph node metastasis and histological grade, which indicates the worse prognosis.
References |
Related Articles |
Metrics
|